Assertion: metastatic pancreatic cancer | /r/HasAspect | many debilitating side effects
Facets:
value: as adjuvant therapy for patients
type: MANNER
Source sentences:
text: Although FOLFIRINOX is more effective than gemcitabine in patients with metastatic pancreatic cancer, doctors have thought that it would have too many debilitating side effects as adjuvant therapy for patients who have recently undergone and are recovering from surgery, explained Udo Rudloff, M.D., Ph.D., of NCI’s Center for Cancer Research, who was not involved in either trial.